330 related articles for article (PubMed ID: 29155089)
1. Genotyping and macrolide resistance of Mycoplasma pneumoniae identified in children with community-acquired pneumonia in Medellín, Colombia.
Copete AR; Aguilar YA; Rueda ZV; Vélez LA
Int J Infect Dis; 2018 Jan; 66():113-120. PubMed ID: 29155089
[TBL] [Abstract][Full Text] [Related]
2. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.
Lung DC; Chan YH; Kwong L; Que TL
Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480
[TBL] [Abstract][Full Text] [Related]
3. [Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].
Yin YD; Cao B; Wang H; Wang RT; Liu YM; Gao Y; Qu JX; Han GJ; Liu YN
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):954-8. PubMed ID: 24503430
[TBL] [Abstract][Full Text] [Related]
4. Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae between children and adults with community-acquired pneumonia: clinical impact of mutations conferring macrolide resistance.
Yoo SJ; Kim HB; Choi SH; Lee SO; Kim SH; Hong SB; Sung H; Kim MN
Antimicrob Agents Chemother; 2012 Dec; 56(12):6393-6. PubMed ID: 23006753
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Clinical Features of Community-Acquired Pneumonia Caused by Macrolide-Resistant
Choi JH; Seong GM; Ko Y; Kim YR; Kim C
Microb Drug Resist; 2019 May; 25(4):577-581. PubMed ID: 30484744
[No Abstract] [Full Text] [Related]
6. Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014.
Kogoj R; Mrvic T; Praprotnik M; Kese D
Euro Surveill; 2015; 20(37):. PubMed ID: 26536357
[TBL] [Abstract][Full Text] [Related]
7. Novel Variant and Known Mutation in 23S rRNA Gene of Mycoplasma pneumoniae, Northern Vietnam, 2023.
Nguyen DD; Ho NT; Dover LG; Vo AHM; Ly HTT; Doan PM; Nguyen HT; Luu NTT; Pham AN; Tran HTT
Emerg Infect Dis; 2024 May; 30(5):1034-1036. PubMed ID: 38573165
[TBL] [Abstract][Full Text] [Related]
8.
Ishiguro N; Sato R; Kikuta H; Nakanishi M; Aoyagi H; Mori T; Nagano N; Tabata Y; Hazama K; Konno M; Yamanaka T; Azuma K; Tanaka H; Narita M; Morita K; Odagawa Y; Ishizaka A; Tsuchida A; Sasaki S; Horino A; Kenri T; Togashi T; Manabe A
J Med Microbiol; 2021 Jun; 70(6):. PubMed ID: 34165424
[TBL] [Abstract][Full Text] [Related]
9. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia.
Morozumi M; Iwata S; Hasegawa K; Chiba N; Takayanagi R; Matsubara K; Nakayama E; Sunakawa K; Ubukata K;
Antimicrob Agents Chemother; 2008 Jan; 52(1):348-50. PubMed ID: 17954691
[TBL] [Abstract][Full Text] [Related]
10. Molecular beacon based real-time PCR p1 gene genotyping, macrolide resistance mutation detection and clinical characteristics analysis of Mycoplasma pneumoniae infections in children.
Li L; Ma J; Guo P; Song X; Li M; Yu Z; Yu Z; Cheng P; Sun H; Zhang W
BMC Infect Dis; 2022 Sep; 22(1):724. PubMed ID: 36068499
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.
Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH
J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608
[TBL] [Abstract][Full Text] [Related]
12. First Description of Macrolide-Resistant
Loconsole D; De Robertis AL; Mallamaci R; Sallustio A; Morea A; Prato R; Quarto M; Martinelli D; Chironna M
Biomed Res Int; 2019; 2019():7168949. PubMed ID: 31008110
[TBL] [Abstract][Full Text] [Related]
13. A study of community-acquired
Yu HX; Zhao MM; Pu ZH; Ju YR; Liu Y
Colomb Med (Cali); 2018 Jun; 49(2):160-163. PubMed ID: 30104808
[TBL] [Abstract][Full Text] [Related]
14. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.
Cao B; Qu JX; Yin YD; Eldere JV
Clin Respir J; 2017 Jul; 11(4):419-429. PubMed ID: 26365811
[TBL] [Abstract][Full Text] [Related]
15. Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.
Tanaka T; Oishi T; Miyata I; Wakabayashi S; Kono M; Ono S; Kato A; Fukuda Y; Saito A; Kondo E; Teranishi H; Tanaka Y; Wakabayashi T; Akaike H; Ogita S; Ohno N; Nakano T; Terada K; Ouchi K
Emerg Infect Dis; 2017 Oct; 23(10):1703-1706. PubMed ID: 28930026
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Lightmix Mycoplasma macrolide assay for detection of macrolide-resistant Mycoplasma pneumoniae in pneumonia patients.
Wagner K; Imkamp F; Pires VP; Keller PM
Clin Microbiol Infect; 2019 Mar; 25(3):383.e5-383.e7. PubMed ID: 30391582
[TBL] [Abstract][Full Text] [Related]
17. Low Incidence of Macrolide-Resistant Mycoplasma pneumoniae between April 2016 and March 2017 in Akita Prefecture, Japan.
Suzuki S; Konno T; Shibata C; Saito H
Jpn J Infect Dis; 2018 Nov; 71(6):477-478. PubMed ID: 30175736
[No Abstract] [Full Text] [Related]
18. Development of an endpoint genotyping assay to detect the Mycoplasma pneumoniae 23S rRNA gene and distinguish the existence of macrolide resistance-associated mutations at position 2063.
Suzuki Y; Seto J; Shimotai Y; Ikeda T; Yahagi K; Mizuta K; Matsuzaki Y; Hongo S
J Microbiol Methods; 2016 Dec; 131():130-134. PubMed ID: 27789313
[TBL] [Abstract][Full Text] [Related]
19. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.
Li X; Atkinson TP; Hagood J; Makris C; Duffy LB; Waites KB
Pediatr Infect Dis J; 2009 Aug; 28(8):693-6. PubMed ID: 19633515
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and mechanism of drug resistance of Mycoplasma pneumoniae in Beijing, China: A multicenter study.
Guo DX; Hu WJ; Wei R; Wang H; Xu BP; Zhou W; Ma SJ; Huang H; Qin XG; Jiang Y; Dong XP; Fu XY; Shi DW; Wang LY; Shen AD; Xin DL
Bosn J Basic Med Sci; 2019 Aug; 19(3):288-296. PubMed ID: 30878034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
